Florence Séjourné

Florence Séjourné

Florence Séjourné is the CEO of AUROBAC THERAPEUTICS, a biopharmaceutical company dedicated to the fight against severe bacterial infections, AMR, and their consequences in acute hospital settings. Florence is also Founder and Board member of the BEAM Alliance, an association representing European biotechs developing new solutions to fight against AMR, to propose and support policies and incentives in antimicrobial R&D to European and International Stakeholders with a unique voice.